| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 200716-85-4 | D-Glutamine,N-[(4-methylPhenyl)diPhenylmethyl]-N2-[(Phenylmethoxy)carbonyl]-; Z-D-Gln(MTT)-OH; Z-D-GLUTAMINE(MTT)-OH; Z-N-DELTA-4-METHYLTRITYL-D-GLUTAMINE; N-ALPHA-CARBOBENZOXY-N-GAMMA-(4-METHYLTRITYL)-D-GLUTAMINE | ![]() | C33H32N2O5 | 详情 | 供应商 | |
| 200716-84-3 | D-Glutamine,N-[(4-methylPhenyl)diPhenylmethyl]-; D-GLUTAMINE(MTT)-OH; H-D-Gln(MTT)-OH; N-DELTA-METHYLTRITYL-D-GLUTAMINE; N-GAMMA-(4-METHYLTRITYL)-D-GLUTAMINE | ![]() | C25H26N2O3 | 详情 | 供应商 | |
| 144317-19-1 | L-Glutamine,N-[(4-methylPhenyl)diPhenylmethyl]-N2-[(Phenylmethoxy)carbonyl]-; Z-Gln(MTT)-OH; Z-GLUTAMINE(MTT)-OH; Z-N-DELTA-METHYLTRITYL-L-GLUTAMINE; N-ALPHA-CARBOBENZOXY-N-GAMMA-(4-METHYLTRITYL)-L-GLUTAMINE | ![]() | C33H32N2O5 | 详情 | 供应商 | |
| 201677-60-3 | L-Alaninamide,N-acetyl-L-alanyl-L-glutaminyl-N-(4-nitroPhenyl)- (9CI); AC-ALA-Gln-ALA-PNA | ![]() | C19H26N6O7 | 详情 | 供应商 | |
| 787539-66-6 | L-Tyrosine,L-prolyl-L-glutaminyl-L-Phenylalanyl- (9CI); H-PRO-Gln-Phe-TYR-OH HCL | ![]() | C28H35N5O7 | 详情 | 供应商 | |
| 121185-80-6 | L-Phenylalaninamide,L-tyrosyl-L-glutaminyl-L-leucyl-L-leucylglycylglycyl-L-arginyl- (9CI); H-TYR-Gln-LEU-LEU-GLY-GLY-ARG-Phe-NH2 | ![]() | C45H69N13O10 | 详情 | 供应商 | |
| 793658-58-9 | L-Tyrosine, L-a-aspartyl-L-prolyl-L-glutaminyl-L-Phenylalanyl-(9CI); H-Asp-Pro-Gln-Phe-Tyr-OH | ![]() | C32H40N6O10 | 详情 | 供应商 | |
| 56104-22-4 | Substance P,1-de-L-arginine-2-de-L-proline-3-de-L-lysine-4-de-L-proline-5-(5-oxo-L-proline)-(9CI); GLP-Gln-Phe-Phe-GLY-LEU-MET-NH2; [GLP5] SUBSTANCE P (5-11); PYR-Gln-Phe-Phe-GLY-LEU-MET-NH2; (PYR5)-SUBSTANCE P (5-11); SUBSTANCE P [PGLU5]-FRAGMENT 5-11; PGLU-Gln-Phe-Phe-GLY-LEU-MET-NH2; pglu5-substance P fragment 5-11; Substance P, fragment 5-11, [pGl5] | ![]() | C41H57N9O9S | 详情 | 供应商 | |
| 81381-50-2 | Substance P,1-de-L-arginine-2-de-L-proline-3-de-L-lysine-4-D-alanine- (9CI); D-ALA-Gln-Gln-Phe-Phe-GLY-LEU-MET-NH2; (D-ALA4)-SUBSTANCE P (4-11); H-D-ALA-Gln-Gln-Phe-Phe-GLY-LEU-MET-NH2; SUBSTANCE P OCTAPEPTIDE D-ALA-4-FRAGMENT 4-11); Substance P, fragment 4-11, (D-Ala4) | ![]() | C44H65N11O10S | 详情 | 供应商 | |
| 137061-48-4 | 腺苷酸环化酶激活肽-38(抗原) | H-HIS-SER-ASP-GLY-ILE-Phe-THR-ASP-SER-TYR-SER-ARG-TYR-ARG-LYS-Gln-MET-ALA-VAL-LYS-LYS-TYR-LEU-ALA-AL; H-HIS-SER-ASP-GLY-ILE-Phe-THR-ASP-SER-TYR-SER-ARG-TYR-ARG-LYS-Gln-MET-ALA-VAL-LYS-LYS-TYR-LEU-ALA-ALA-VAL-LEU-GLY-LYS-ARG-TYR-LYS-Gln-ARG-VAL-LYS-ASN-LYS-NH2; HIS-SER-ASP-GLY-ILE-Phe-THR-ASP-SER-TYR-SER-ARG-TYR-ARG-LYS-Gln-MET-ALA-VAL-LYS-LYS-TYR-LEU-ALA-ALA-VAL-LEU-GLY-LYS-ARG-TYR-LYS-Gln-ARG-VAL-LYS-ASN-LYS-NH2; HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2; ADENYLATE CYCLASE ACTIVATING PEPTIDE-38; ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE-38; PACAP (1-38), AMIDE, HUMAN, OVINE, RAT; PACAP (1-38), HUMAN, OVINE, RAT; PACAP (1-38) (HUMAN, SHEEP, RAT) | 无 | C203H331N63O53S1 | 详情 | 供应商 |
| 866552-34-3 | HIS-ALA-ASP-ALA-VAL-Phe-THR-ALA-ALA-TYR-ALA-ARG-LEU-ARG-LYS-Gln-MET-ALA-ALA-LYS-LYS-ALA-LEU-ALA-ALA-; [ALA2,8,9,11,19,22,24,25,27,28]-VIP; HIS-ALA-ASP-ALA-VAL-Phe-THR-ALA-ALA-TYR-ALA-ARG-LEU-ARG-LYS-Gln-MET-ALA-ALA-LYS-LYS-ALA-LEU-ALA-ALA-ILE-ALA-ALA-NH2 | ![]() | C131H219N41O33S | 详情 | 供应商 | |
| 152286-31-2 | TYR-GLU-VAL-HIS-HIS-Gln-LYS-LEU-VAL-Phe-Phe | H-TYR-GLU-VAL-HIS-HIS-Gln-LYS-LEU-VAL-Phe-Phe-OH; AMYLOID BETA-PROTEIN (10-20); AMYLOID BETA-PEPTIDE (10-20) (HUMAN); AMYLOID BETA-PROTEIN FRAGMENT 10-20; H-TYR-GLU-VAL-HIS-HIS-Gln-LYS-LEU-VAL-Phe-Phe-OH; BETA-AMYLOID (10-20); YEVHHQKLVFF; TYR-GLU-VAL-HIS-HIS-Gln-LYS-LEU-VAL-Phe-Phe; amyloid B-protein fragment 10-20 | ![]() | C71H99N17O16 | 详情 | 供应商 |
| 107015-83-8 | 淀粉-Β-蛋白片段12-28 | H-VAL-HIS-HIS-Gln-LYS-LEU-VAL-Phe-Phe-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-OH; H-VAL-HIS-HIS-Gln-LYS-LEU-VAL-Phe-Phe-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-OH; BETA-AMYLOID (12-28); BETA-AMYLOID PEPTIDE [12-28], HUMAN; ALZHEIMER'S DISEASE BETA-PROTEIN (12-28); AMYLOID, BETA- (12-28), HUMAN; AMYLOID BETA-PROTEIN (12-28); AMYLOID-BETA PROTEIN (12-28), HUMAN; AMYLOID BETA-PROTEIN FRAGMENT 12-28 | ![]() | C89H135N25O25 | 详情 | 供应商 |
| 166090-74-0 | H-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA-OH | H-ASP-ALA-GLU-Phe-ARG-HIS-ASP-SER-GLY-TYR-GLU-VAL-HIS-HIS-Gln-LYS-LEU-VAL-Phe-Phe-ALA-GLU-ASP-VAL-GL; PREDOMINANT AMYLOID B-PROTEIN FRAGMENT; ASP-ALA-GLU-Phe-ARG-HIS-ASP-SER-GLY-TYR-GLU-VAL-HIS-HIS-Gln-LYS-LEU-VAL-Phe-Phe-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-LEU-MET-VAL-GLY-GLY-VAL-VAL-ILE-ALA; ASP-ALA-GLU-Phe-GLY-HIS-ASP-SER-GLY-Phe-GLU-VAL-ARG-HIS-Gln-LYS-LEU-VAL-Phe-Phe-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-LEU-MET-VAL-GLY-GLY-VAL-VAL-ILE-ALA; BAP 1-42; BETA-AMYLOID, SODIUM SALT; BETA-AMYLOID PEPTIDE (1-40), MOUSE, RAT; BETA-AMYLOID PEPTIDE (1-40), RAT; BETA-AMYLOID PEPTIDE (1-42), RAT | 无 | C203H311N55O60S | 详情 | 供应商 |
| 217082-57-0 | APELIN PRECURSOR (61-77) (HUMAN, BOVINE, MOUSE, RAT) TRIFLUOROACETATE; H-LYS-Phe-ARG-ARG-Gln-ARG-PRO-ARG-LEU-SER-HIS-LYS-GLY-PRO-MET-PRO-Phe-OH TRIFLUOROACETATE; APELIN-17 (HUMAN, BOVINE, MOUSE, RAT) TRIFLUOROACETATE; APELIN PRECURSOR (61-77) (HUMAN, BOVINE, MOUSE, RAT) TRIFLUOROACETATE; PREPROAPELIN (61-77) (HUMAN, BOVINE, MOUSE, RAT) TRIFLUOROACETATE | ![]() | C96H156N34O20S | 详情 | 供应商 | |
| 230299-95-3 | LEU-VAL-LYS-PRO-ARG-THR-SER-ARG-THR-GLY-PRO-GLY-ALA-TRP-Gln-GLY-GLY-ARG-ARG-LYS-Phe-ARG-ARG-Gln-ARG-; APELIN-36, MOUSE, RAT; APELIN-36 (RAT, MOUSE); LEU-VAL-LYS-PRO-ARG-THR-SER-ARG-THR-GLY-PRO-GLY-ALA-TRP-Gln-GLY-GLY-ARG-ARG-LYS-Phe-ARG-ARG-Gln-ARG-PRO-ARG-LEU-SER-HIS-LYS-GLY-PRO-MET-PRO-Phe; LEU-VAL-LYS-PRO-ARG-THR-SER-ARG-THR-GLY-PRO-GLY-ALA-TRP-Gln-GLY-GLY-ARG-ARG-LYS-Phe-ARG-ARG-Gln-ARG-PRO-ARG-LEU-SER-HIS-LYS-GLY-PRO-MET-PRO-Phe | ![]() | C185H304N68O43S | 详情 | 供应商 | |
| 236098-40-1 | Phe-GLY-GLY-Phe-THR-GLY-ALA-ARG-LYS-SER-ALA-ARG-LYS-ARG-LYS-ASN-Gln; [ARG14,LYS15]NOCICEPTIN; [ARG14, LYS15]NOCICEPTIN/ORPHANIN FQ; [ARG14,LYS15] ORPHANIN FQ; Phe-GLY-GLY-Phe-THR-GLY-ALA-ARG-LYS-SER-ALA-ARG-LYS-ARG-LYS-ASN-Gln | ![]() | C82H137N31O22 | 详情 | 供应商 | |
| 96736-12-8 | (D-ARG1,D-Phe5,D-TRP7·9,LEU11)-SUBSTANCE P | D-ARG-PRO-LYS-PRO-D-Phe-Gln-D-TRP-Phe-D-TRP-LEU-LEU-NH2; [D-ARG1, D-Phe5, D-TRP7,9, LEU11]-SUBSTANCE P; D-ARG-PRO-LYS-PRO-D-Phe-Gln-D-TRP-Phe-D-TRP-LEU-LEU-NH2; H-D-ARG-PRO-LYS-PRO-D-Phe-Gln-D-TRP-Phe-D-TRP-LEU-LEU-NH2; substance P, Phe(5)-Trp(7,9)-Leu(11)-; Substance P, [D-Arg1, D-Phe5, D-Trp7,9, Leu11]; AntagonistD, D-Arg-Pro-Lys-Pro-D-Phe-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2; M.W. 1516.85 C79H109N19O12; D-Arg-L-Pro-L-Lys-L-Pro-D-Phe-L-Gln-D-Trp-L-Phe-D-Trp-L-Leu-L-Leu-NH2 | ![]() | C79H109N19O12 | 详情 | 供应商 |
| 40944-53-4 | [ASU1,6,ARG8]-VASOPRESSIN; TYR-Phe-Gln-ASN-ASU-PRO-ARG-GLY-NH2; VASOPRESSIN, [ASU196,ARG8]; [ASU1,6,ARG8]-VASOPRESSIN; CYCLO(TYR-Phe-Gln-ASN-ASU)-PRO-ARG-GLY-NH2; DEAMINO-DICARBA-ARGININE-VASOPRESSIN | ![]() | C48H68N14O12 | 详情 | 供应商 | |
| 90984-99-9 | ARG-ARG-SER-SER-CYS-Phe-GLY-GLY-ARG-ILE-ASP-ARG-ILE-GLY-ALA-Gln-SER-GLY-LEU-GLY-CYS-ASN-SER-Phe-ARG- | ARG-ARG-SER-SER-CYS-Phe-GLY-GLY-ARG-ILE-ASP-ARG-ILE-GLY-ALA-Gln-SER-GLY-LEU-GLY-CYS-ASN-SER-Phe-ARG-; H-ARG-ARG-SER-SER-CYS-Phe-GLY-GLY-ARG-ILE-ASP-ARG-ILE-GLY-ALA-Gln-SER-GLY-LEU-GLY-CYS-ASN-SER-Phe-ARG-TYR-OH; ATRIAL NATRIURETIC PEPTIDE RAT FRAGMENT 3-28; ATRIAL NATRIURETIC FACTOR (3-28) (RAT); ATRIAL NATRIURETIC PEPTIDE (3-28), RAT; A-TYPE (ATRIAL) NATRIURETIC PEPTIDE (RAT, 3-28); ARG-ARG-SER-SER-CYS-Phe-GLY-GLY-ARG-ILE-ASP-ARG-ILE-GLY-ALA-Gln-SER-GLY-LEU-GLY-CYS-ASN-SER-Phe-ARG-TYR; ANP (RAT, 3-28); ANP (3-28), RAT | ![]() | C119H189N43O36S2 | 详情 | 供应商 |